top of page
Group 89 (1).png

TRANSACTIONS

A holistic approach to transactions that value every journey

+

25

completed transactions

~R$

25

bn

in successful operations

MAIN

TRANSACTIONS

Transactions marked with * were conducted by LUCCE's partners at other firms.
AF_Marca_Luce_com_tagline_RGB_Colorido.png
oggi.png
marilan.png
Undisclosed
Exclusive financial advisor in the joint venture between Oggi Sorvetes and Grupo Marilan
November 2024
unnamed.jpg
unnamed (2).png
Undisclosed*
Exclusive financial advisor to Vitagema on its sale to
Granja Faria
April 2024
unnamed (11).png
R$1.1bn*

Global Coordinator in Westwing’s IPO
February 2021
unnamed (23).png
unnamed (24).png
R$800m*
Exclusive financial advisor to EB Capital on EB Fibra FIP Multiestratégia’s Private Placement
November 2020
unnamed (1).jpg
unnamed (25).png
Undisclosed*
Financial advisor to Treecorp on securing part of the funds invested in ZeeDog
October 2020
unnamed (27).png
unnamed (26).png
Undisclosed*
Exclusive financial advisor to Alibra on its sale to Axxon Group
February 2020
Frame 434 (15).png
Undisclosed*
Financial advisor to Caixa Participações by providing a Valuation Report
May 2018
Frame 434 (17).png
Undisclosed*
Financial advisor to Coelba by providing a Valuation Report
December 2017
Frame 426 (4).png
Undisclosed*
Financial advisor to Banco
do Brasil’ Board of

Directors by providing a Valuation Report
December 2016
unnamed (32).png
unnamed (31).png
Undisclosed*
Exclusive financial advisor to Fras-le on the sale of an equity stake to Gávea
April 2016
Frame 434 (21).png
Undisclosed*
Financial advisor to Dasa’s Board of Directors by providing a Fairness Opinion as part of its delisting process
January 2016
unnamed (33).png
unnamed (34).png
R$757m*
Exclusive financial advisor to Somos on the acquisition of Saraiva Educação
June 2015
Frame 434 (24).png
R$707m*
Exclusive financial advisor to EDP on the acquisition of 50% of Pecém I
May 2015
unnamed (17).png
unnamed (18).png
Undisclosed*
Exclusive financial advisor to Medquímica on its sale to Lupin
April 2015
Frame 434 (26).png
R$1.1bn*
Joint Bookrunner in
Smiles’ IPO
April 2013
valid.png
vmark.png
R$1.0bn*
Exclusive financial advisor to Valid on the acquisition of Vmark
December 2012
Frame 434 (28).png
R$1.4bn*
Joint Bookrunner in Fibria’s Follow-on
May 2012
Frame 426 (6).png
R$200m*
Joint Bookrunner in Minerva’s convertible debenture
July 2011
Frame 434 (27).png
R$1.0bn*
Financial advisor to Marfrig on its Follow-on
December 2012
Frame 434 (29).png
R$2.2bn*
Financial advisor to Vale Fertilizantes by providing a Valuation Report as part of its delisting process
December 2011
Frame 434 (29).png
R$6.9bn*
Exclusive financial advisor in the incorporation of Vale Fosfatados by Vale Fertilizantes
October 2010
Frame 434 (29).png
fosfertil.png
R$2.2bn*
Exclusive financial advisor to Fosfertil by completing a mandatory tag-along tender offer for all ON shares
May 2010
unnamed (35).png
unnamed (36).png
R$600m*
Exclusive financial advisor to IUNI on its sale to Kroton Educacional
March 2010
Frame 434 (31).png
R$750m*
Joint Bookrunner in Anhanguera Educacional’s Follow-on
December 2009
Frame 434 (27).png
R$1.5bn*
Joint Bookrunner in Marfrig’s Follow-on
November 2009
unnamed (37).png
R$665m*
Joint Bookrunner in Brookfield Incorporações ’s Follow-on
October 2009
unnamed (38).png
unnamed (36).png
R$285m*
Deal advisor
on the sale of Kroton’s
co-controlling stake to
Advent International
June 2009
Lucce.png

We are committed partners in building

your next chapter.

Group 76 (3).png

We believe that every company deserves financial advisory that values its achievements and sets the foundation for long-term prosperity, turning expectations into successful stories.

bottom of page